Literature DB >> 34890296

Thioredoxin Prevents Loss of UCP2 in Hyperoxia via MKK4-p38 MAPK-PGC1α Signaling and Limits Oxygen Toxicity.

Somasundaram Raghavan1, Venkatesh Kundumani-Sridharan1, Sudhir Kumar1, Carl W White2, Kumuda C Das1.   

Abstract

Administration of high concentrations of oxygen (hyperoxia) is one of few available options to treat acute hypoxemia-related respiratory failure, as seen in the current coronavirus disease (COVID-19) pandemic. Although hyperoxia can cause acute lung injury through increased production of superoxide anion (O2•-), the choice of high-concentration oxygen administration has become a necessity in critical care. The objective of this study was to test the hypothesis that UCP2 (uncoupling protein 2) has a major function of reducing O2•- generation in the lung in ambient air or in hyperoxia. Lung epithelial cells and wild-type; UCP2-/-; or transgenic, hTrx overexpression-bearing mice (Trx-Tg) were exposed to hyperoxia and O2•- generation was measured by using electron paramagnetic resonance, and lung injury was measured by using histopathologic analysis. UCP2 expression was analyzed by using RT-PCR analysis, Western blotting analysis, and RNA interference. The signal transduction pathways leading to loss of UCP2 expression were analyzed by using IP, phosphoprotein analysis, and specific inhibitors. UCP2 mRNA and protein expression were acutely decreased in hyperoxia, and these decreases were associated with a significant increase in O2•- production in the lung. Treatment of cells with rhTrx (recombinant human thioredoxin) or exposure of Trx-Tg mice prevented the loss of UCP2 protein and decreased O2•- generation in the lung. Trx is also required to maintain UCP2 expression in normoxia. Loss of UCP2 in UCP2-/- mice accentuated lung injury in hyperoxia. Trx activates the MKK4-p38MAPK (p38 mitogen-activated protein kinase)-PGC1α (PPARγ [peroxisome proliferator-activated receptor γ] coactivator 1α) pathway, leading to rescue of UCP2 and decreased O2•- generation in hyperoxia. Loss of UCP2 in hyperoxia is a major mechanism of O2•- production in the lung in hyperoxia. rhTrx can protect against lung injury in hyperoxia due to rescue of the loss of UCP2.

Entities:  

Keywords:  PGC1α; UCP2; hyperoxia; lung injury; thioredoxin

Mesh:

Substances:

Year:  2022        PMID: 34890296      PMCID: PMC8937245          DOI: 10.1165/rcmb.2021-0219OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  33 in total

1.  Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

Authors:  Julie St-Pierre; Stavit Drori; Marc Uldry; Jessica M Silvaggi; James Rhee; Sibylle Jäger; Christoph Handschin; Kangni Zheng; Jiandie Lin; Wenli Yang; David K Simon; Robert Bachoo; Bruce M Spiegelman
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

Review 2.  Uncoupling to survive? The role of mitochondrial inefficiency in ageing.

Authors:  M D Brand
Journal:  Exp Gerontol       Date:  2000-09       Impact factor: 4.032

3.  Superoxide activates mitochondrial uncoupling proteins.

Authors:  Karim S Echtay; Damien Roussel; Julie St-Pierre; Mika B Jekabsons; Susana Cadenas; Jeff A Stuart; James A Harper; Stephen J Roebuck; Alastair Morrison; Susan Pickering; John C Clapham; Martin D Brand
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

4.  Thioredoxin-deficient mice, a novel phenotype sensitive to ambient air and hypersensitive to hyperoxia-induced lung injury.

Authors:  Kumuda C Das
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-24       Impact factor: 5.464

5.  Thioredoxin Activates MKK4-NFκB Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells.

Authors:  Venkatesh Kundumani-Sridharan; Jaganathan Subramani; Kumuda C Das
Journal:  J Biol Chem       Date:  2015-05-31       Impact factor: 5.157

6.  Reduced fertility in female mice lacking copper-zinc superoxide dismutase.

Authors:  Y S Ho; M Gargano; J Cao; R T Bronson; I Heimler; R J Hutz
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

7.  Thioredoxin reverses age-related hypertension by chronically improving vascular redox and restoring eNOS function.

Authors:  Rob H P Hilgers; Venkatesh Kundumani-Sridharan; Jaganathan Subramani; Leon C Chen; Luis G Cuello; Nancy J Rusch; Kumuda C Das
Journal:  Sci Transl Med       Date:  2017-02-08       Impact factor: 17.956

8.  Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia.

Authors:  Y S Ho; R Vincent; M S Dey; J W Slot; J D Crapo
Journal:  Am J Respir Cell Mol Biol       Date:  1998-04       Impact factor: 6.914

9.  Hyperoxia decreases glycolytic capacity, glycolytic reserve and oxidative phosphorylation in MLE-12 cells and inhibits complex I and II function, but not complex IV in isolated mouse lung mitochondria.

Authors:  Kumuda C Das
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

10.  High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure.

Authors:  Ricard Mellado-Artigas; Bruno L Ferreyro; Federico Angriman; María Hernández-Sanz; Egoitz Arruti; Antoni Torres; Jesús Villar; Laurent Brochard; Carlos Ferrando
Journal:  Crit Care       Date:  2021-02-11       Impact factor: 9.097

View more
  3 in total

1.  Does UCP2 Couple Hyperoxia to Lung Injury?

Authors:  Jennifer L Larson-Casey; A Brent Carter
Journal:  Am J Respir Cell Mol Biol       Date:  2022-03       Impact factor: 6.914

Review 2.  Oxygen toxicity: cellular mechanisms in normobaric hyperoxia.

Authors:  Ricardo Alva; Maha Mirza; Adam Baiton; Lucas Lazuran; Lyuda Samokysh; Ava Bobinski; Cale Cowan; Alvin Jaimon; Dede Obioru; Tala Al Makhoul; Jeffrey A Stuart
Journal:  Cell Biol Toxicol       Date:  2022-09-16       Impact factor: 6.819

Review 3.  Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.

Authors:  Noha A Kamel; Nasser S M Ismail; Ibrahim S Yahia; Khaled M Aboshanab
Journal:  Medicina (Kaunas)       Date:  2021-12-23       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.